About
Michael D. West, Ph.D. became is Chief Executive Officer of BioTime Inc, a biotechnology company development medical treatments using stem cells in the field of regenerative medicine. BioTime stock is listed on the NYSE:MKT exchange, ticker symbol BTX. Dr. West was appointed CEO of BioTime in October 2007, and has served on the company's Board of Directors since 2002. Prior to becoming our Chief Executive Officer, Dr. West served as Chief Executive Officer, President, and Chief Scientific Officer of Advanced Cell Technology, Inc., a company engaged in developing human stem cell technology for use in regenerative medicine. Dr. West also founded Geron Corporation of Menlo Park, California, for which he secured venture capital investment from Kleiner Perkins Caufield & Byers, Venrock and others. From 1990 to 1998 he was a Director and Vice-President, where he initiated and managed programs in telomerase diagnostics, oligonucleotide-based telomerase inhibition as anti-tumor therapy, and t
Position in the VCSift Database
- • 3,360 investors hold the CEO role in VCSift. Michael D West is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
Find more investors like Michael
Search Investors